DioGenix attracts $3.2 mln
DioGenix said Thursday that it has received $3.2 million in funding. Nerveda, a life sciences fund, was one of the investors. Based in Gaithersburg, Maryland, DioGenix is a developer of molecular tests that measure well-established human biology.
5 December 2013•3 mins read
